Fernandes DT, van Heerden WFP, Ribeiro ACP, Brandão TB, Mello ESd, Rivera C, et al. Different methods of cell quantification can lead to different results: a comparison of digital methods using a pilot study of dendritic cells in HIV-positive patients. Med Oral Patol Oral Cir Bucal. 2020 May 1;25 (3):e431-8.
doi:10.4317/medoral.23472
https://dx.doi.org/doi:10.4317/medoral.23472
1. Thrift AP, Chiao EY. Are Non-HIV Malignancies Increased in the HIV-Infected Population?. Curr Infect Dis Rep. 2018;20:22. |
PMid:29804238 |
2. Clifford GM, Polesel J, Rickenbach M, Dal Maso L, Keiser O, Kofler A, et al. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst. 2005;97:425-32. |
PMid:15770006 |
3. Hessol NA, Pipkin S, Schwarcz S, Cress RD, Bacchetti P, Scheer S. The impact of highly active antiretroviral therapy on non-AIDS-defining cancers among adults with AIDS. Am J Epidemiol. 2007;165:1143-53. |
PMid:17344204 |
4. Bunn BK, van Heerden WFP. HIV/AIDS associated malignancies of the head and neck. SADJ. 2012;67:590-2. |
PMid:23957103 |
5. Mourad WF, Hu KS, Shasha D, Concert C, Ishihara D, Lin W, et al. Long-term Outcome of Seropositive HIV Patients with Head and Neck Squamous Cell Carcinoma Treated with Radiation Therapy and Chemotherapy. Anticancer Res. 2013;33:5511-6. |
PMid:24324090 |
6. Grew DJ, Cooper BT, Nguy S, Halperin J, Sanfilippo NJ. Toxicity and Disease-Related Outcomes after Radiotherapy for Head and Neck Cancer in Human Immunodeficiency Virus-Positive Patients. Front Oncol. 2014;4:316. |
PMid:25426448 PMCid:PMC4226241 |
7. Bernier J, Cooper JS, Pajak TF, van Glabbeke M, Bourhis J, Forastiere A, et al. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck. 2005;27:843-50. |
PMid:16161069 |
8. Gillison ML. Oropharyngeal cancer: a potential consequence of concomitant HPV and HIV infection. Curr Opin Oncol. 2009;21:439-44. |
PMid:19587593 |
9. Picard A, Arowas L, Piroth L, Heard I, Ferry T. Head and neck squamous cell carcinoma in people living with HIV in France. Med Mal Infect. 2018;48:503-8. |
PMid:29887186 |
10. Kao GD, Devine P, Mirza N. Oral cavity and oropharyngeal tumors in human immunodeficiency virus-positive patients: acute response to radiation therapy. Arch Otolaryngol Head Neck Surg. 1999;125:873-6. |
PMid:10448734 |
11. Spano J-P, Costagliola D, Katlama C, Mounier N, Oksenhendler E, Khayat D. AIDS-related malignancies: state of the art and therapeutic challenges. J Clin Oncol. 2008;26:4834-42. |
PMid:18591544 |
12. Bennaceur K, Chapman J, Brikci-Nigassa L, Sanhadji K, Touraine J, Portoukalian J. Dendritic cells dysfunction in tumour environment. Cancer Lett. 2008;272:186-96. |
PMid:18585853 |
13. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. (Review). Nature. 1998;392:245-52. |
PMid:9521319 |
14. Lombardi T, Hauser C, Budtz-Jörgensen E. Langerhans cells: structure, function and role in oral pathological conditions. J Oral Pathol Med. 1993;22:193-202. |
PMid:8315598 |
15. Sobhani I, Walker F, Roudot-Thoraval F, Abramowitz L, Johanet H, Hénin D, et al. Anal carcinoma: incidence and effect of cumulative infections. AIDS. 2004;18:1561-9. |
PMid:15238774 |
16. Weber F, Byrne SN, Le S, Brown DA, Breit SN, Scolyer RA, et al. Transforming growth factor-β1 immobilises dendritic cells within skin tumours and facilitates tumour escape from the immune system. Cancer Immunol Immunother. 2005;54:898-906. |
PMid:15776284 |
17. Upadhyay R, Upadhyay J, Rao N. A comparative analysis of langerhans cell in oral epithelial dysplasia and oral squamous cell carcinoma using antibody CD-1a. J Cancer Res Ther. 2012;8:591-7. |
PMid:23361280 |
18. Galan A, Ko CJ. Langerhans cells in squamous cell carcinoma vs. pseudoepitheliomatous hyperplasia of the skin. J Cutan Pathol. 2007;34:950-2. |
PMid:18001421 |
19. Zimmermmann JB, Gobbi H, Alves MJM, Quirino MG, Melo VH. Langerhans cell density in cervical intraepithelial neoplasia associated with human papillomavirus infection in Hiv-infected and HIV-noninfected brazilian women. Int J Gynecol Cancer. 2012;22:1291-6. |
PMid:22932260 |
20. Cruz SHA, Nadal SR, Nadal CRM, Calore EE. Evaluation of Langerhans cells counts comparing HIV-positive and negative anal squamous cell-carcinoma patients. Acta Cir Bras. 2012;27:720-6. |
PMid:23033134 |
21. Nandwani R, Gazzard BG, Barton SE, Hawkins DA, Zemelman V, Staughton RC. Does HIV disease progression influence epidermal Langerhans cell density?. Br J Dermatol. 1996;134:1087-92. |
PMid:8763430 |
22. Gomes JO, de Vasconcelos Carvalho M, Fonseca FP, Gondak RO, Lopes MA, Vargas PA. CD1a+ and CD83+ Langerhans cells are reduced in lower lip squamous cell carcinoma. J Oral Pathol Med. 2016;45:433-9. |
PMid:26661374 |
23. Gondak RO, Alves DB, Silva LFF, Mauad T, Vargas PA. Depletion of Langerhans cells in the tongue from patients with advanced-stage acquired immune deficiency syndrome: Relation to opportunistic infections. Histopathology. 2012;60:497-503. |
PMid:22168427 |
24. Gondak R, Mauad T, Schultz L, Soares F, Kowalski LP, Vargas PA. Decreased CD1a +, CD83 + and factor XIIIa + dendritic cells in cervical lymph nodes and palatine tonsils of AIDS patients. Histopathology. 2014;64:234-41. |
PMid:24192235 |
25. Jardim JF, Gondak R, Galvis MM, Pinto CAL, Kowalski LP. A decreased peritumoral CD1a+ cell number predicts a worse prognosis in oral squamous cell carcinoma. Histopathology. 2018;72:905-13. |
PMid:29023924 |
26. Wagner VP, Webber LP, Curra M, Klein IP, Meurer L, Carrad VC, et al. Bryne's grading system predicts poor disease-specific survival of oral squamous cell carcinoma: a comparative study among different histologic grading systems. Oral Surg Oral Med Oral Pathol Oral Radiol. 2017;123:688-96. |
PMid:28411003 |
27. Costa NL, Gonçalves AS, Martins AFL, Arantes DAC, Silva TA, Batista AC. Characterization of dendritic cells in lip and oral cavity squamous cell carcinoma. J Oral Pathol Med. 2016;45:418-24. |
PMid:26514660 |
28. Kindt N, Descamps G, Seminerio I, Bellier J, Lechien JR, Pottier C, et al. Langerhans cell number is a strong and independent prognostic factor for head and neck squamous cell carcinomas. Oral Oncol. 2016;62:1-10. |
PMid:27865360 |
29. Pellicioli ACA, Bingle L, Farthing P, Lopes MA, Martins MD, Vargas PA. Immunosurveillance profile of oral squamous cell carcinoma and oral epithelial dysplasia through dendritic and T-cell analysis. J Oral Pathol Med. 2017;46:928-33. |
PMid:28585308 |
30. Hovav AH. Dendritic cells of the oral mucosa. Mucosal Immunol. 2014;7:27-7. |
PMid:23757304 |